---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-022935"
form_type: "8-K"
ticker: "CPIX"
cik: "0001087294"
company_name: "CUMBERLAND PHARMACEUTICALS INC"
filed_at: "2023-06-22T23:59:59+00:00"
generated_at: "2026-06-13T18:46:33.467806+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "low"
source: SEC EDGAR
---

# Cumberland settles breach-of-contract suit with Melinta/Targanta, receives undisclosed consideration

## Summary
- Settlement finalized June 16, 2023; case closed in NY Supreme Court.
- Company had sought $1M in milestone payments for NDA/sNDA filings.
- Defendants obtained license to Company patents for product development.
- Original action filed Feb 2022; refiled Nov 2022 after jurisdiction change.

## SEC filing metadata
- accession: 0001628280-23-022935
- form_type: 8-K
- ticker: CPIX
- cik: 0001087294
- company_name: CUMBERLAND PHARMACEUTICALS INC
- filed_at: 2023-06-22T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: low
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1087294/000162828023022935/0001628280-23-022935-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1087294/000162828023022935/cpix-20230616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-022935
- JSON: https://secwatch.observer/filing/0001628280-23-022935.json
- Plain text: https://secwatch.observer/filing/0001628280-23-022935.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.